Blockade of the development of opioid tolerance and dependence by methylene blue

Yaoxue Xuebao

Volumn 34, Issue 8, 1999, Pages 576-581

  Zang, Mengwei ^a   Meng, Aimin ^a   Shen, Qi ^a   Sun, Yue ^a   Wang, Qing ^a   Liu, Jingsheng ^a  

^a INSTITUTE OF BASIC MEDICAL SCIENCES   (China)

Author keywords

Cyclic AMP; Cyclic GMP; Intercellular free calcium; Methylene blue; Nitric oxide synthase; Opiate dependence

Indexed keywords

EID: 0041734599     PISSN: 05134870     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (15)

1. Katsuki SW, Mittal AC, Murad F. Stimulation of guanylate cyclase by sodium nitroprusside, nitroglycerin and nitric oxide in various tissue preparations. Adv Cyclic Nucleotide Res, 1977,3:23
2. Przewlocki R, Machelska H, Przewlocki B. Inhibition of nitric oxide synthase enhances morphine antinociception in the rat spinal cord. Life Sci, 1993,53:PL1
3. Granados-Soto V, Rufino MO, Gomes LD. Evidence for the involvement of the nitric oxide-cGMP pathway in the antinociception of morphine in the formalin test. Eur J Pharmacol, 1997,340:177
4. Zang MW, Shen Q, Wang Q, et al. Effect of opiate on receptor-mediated adenylate cyclase-cAMP signal system in NG-LNCXiNOS cell with the stable expression of inducible nitric oxide synthase gene. Acta Pharm Sin, 1999, in press
5. Zang MW, Shen Q, Liu JS. Effect of nitric oxide synthase inhibitor on signal transduction pathway of opiate tolerance and dependence in NG108-15 cells expressing iNOS gene. Natl Med J China, 1999, in press
6. Prather PL, Tsai AW, Law PY. Mu and delta opioid receptor desensitization in undifferentiated human neuroblastoma SHSY5Y cells. J Pharmcol Exp Ther, 1994,270:177
7. 1 receptor system in neuroblastoma x glioma (NG108-15) hybrid cells. J Neurochem, 1995,64:2449
8. Bredt DS, Snyder SH. Isolation of nitric oxide synthase, a calmodulin-requiring enzyme. Proc Natl Acad Sci USA, 1990,87:682
9. Liu JS, Li YM, Wang ZG. Radioimmunoassay for guanosine 3′, 5′-cyclic monophosphate. Acta Pharmacol Sin, 1981,2:67
10. Babey AM, Kolesnikov Y, Cheng J, et al. Nitric oxide and opioid tolerance. Neuropharmacology, 1994, 33: 1463
11. Xu JY, Tseng LF. Nitric oxide/cyclic guanosine monophosphate system in the spinal cord differentially modulates intracerebroventricularly administered morphine- and beta-endorphin-induced antinociception in the mouse. J Pharmacol Exp Ther, 1995,274:8
12. Xu JY, Tseng LF. Role of nitric oxide/cyclic GMP in icv administered beta-endorphin- and (+)-cis-dioxolane-induced antinociception in the mouse. J Pharmacol Exp Ther, 1998,284:455
13. Wolin MS, Cherry PD, Roclenburg JM, et al. Methylene blue inhibits vasodilatation of skeletal muscle arterioles to acetylcholine and nitric oxide via the extracellular generation of superoxide anion. J Pharmacol Exp Ther, 1990,254:872
14. Luo D, Das S, Vincent SR. Effects of methylene blue and LY 83583 on neuronal nitric oxide synthase and NADPH-diaphorase. Eur J Pharmacol, 1995,290:247
15. Herman BH, Vocci F, Bridge P. The effects of NMDA receptor antagonists and nitric oxide synthase inhibitors on opioid tolerance and withdrawal: medication development issues for opiate addiction. Neuropsychopharmacology, 1995,13:271